The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Du, Xiao Jing ^a   Tang, Ling Long ^a   Mao, Yan Ping ^a   Sun, Ying ^a   Zeng, Mu Sheng ^a   Kang, Tie Bang ^a   Jia, Wei Hua ^a   Lin, Ai Hua ^b   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GLOBULIN; SERUM ALBUMIN; TAXANE DERIVATIVE; ALBUMINOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NEUTROPHIL COUNT; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; BLOOD; DISEASE FREE SURVIVAL; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; TIME; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALBUMINS; DISEASE-FREE SURVIVAL; FEMALE; GLOBULINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899518624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094473     Document Type: Article

References (37)

1. Muir C, Waterhouse J, Mack T (1987) Cancer incidence in five continents. IARC Sci Publ 5: 1-970.
2. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-54. (Pubitemid 40812341)
3. Lee AW, Lin JC, Ng WT (2012) Current Management of Nasopharyngeal Cancer. Semin Radiat Oncol 22: 233-44.
4. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, et al. (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64: 47-56. (Pubitemid 41831208)
5. Kwong D, Sham J, Choy D (1994) The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30: 1029-36. (Pubitemid 24362510)
6. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, et al. (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64: 57-62. (Pubitemid 41831209)
7. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350: 2461-2470. (Pubitemid 38736543)
8. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-54. (Pubitemid 40812341)
9. Muliawati Y, Haroen H, Rotty LW (2012) Cancer anorexia - cachexia syndrome. Acta Med Indones 44: 154-62.
10. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12: 223-6.
11. Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9: 69.
12. Li G, Gao J, Liu ZG, Tao YL, Xu BQ, et al. (2013) Influence of pretreatment ideal body weight percentile and albumin on the prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. Head Neck in press.
13. An X, Ding PR, Wang FH, Jiang WQ, Li YH (2011) Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 32: 317-24.
14. He JR, Shen GP, Ren ZF, Qin H, Cui C, et al. (2012) Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 34: 1769-76.
15. Jin Y, Ye X, He C, Zhang B, Zhang Y (2013) Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma. Head Neck in press.
16. Li J, Jiang R, Liu WS, Liu Q, Xu M, et al. (2013) A Large Cohort Study Reveals the Association of Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio with Favorable Prognosis in Nasopharyngeal Carcinoma. PLoS One 8: e83069.
17. Xia WX, Ye YF, Lu X, Wang L, Ke LR, et al. (2013) The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy. PLoS One 8: e76958.
18. Xia WX, Zhang HB, Shi JL, Lu X, Wang L, et al. (2013) A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer 49: 2152-60.
19. Igarashi T, Tobe T, Kuramochi H, Akakura K, Ichikawa T, et al. (2001) Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 31: 13-17. (Pubitemid 32236881)
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) American Joint Committee on Cancer manual for staging of cancer, 7th ed. Philadelphia: JB Lippincott. 649p.
21. Azab BN, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V, et al. (2013) Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J Surg 206: 764-70.
22. Azab B, Kedia S, Shah N, Vonfrolio S, Lu W, et al. (2013) The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis 28: 1629-36.
23. Maltoni M, Amadori D (2002) Prognosis in advanced cancer. Hematol Oncol Clin North Am 16: 715-729. (Pubitemid 34827377)
24. Seaton K (2001) Albumin concentration controls cancer. J Natl Med Assoc 93: 490-3.
25. Laursen I, Briand P, Lykkesfeldt AE (1990) Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 10: 343-51. (Pubitemid 20187275)
26. Sonnenschein C, Soto AM, Michaelson CL (1996) Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol 59: 147-54. (Pubitemid 27036266)
27. Chandra RK (1999) Nutrition and immunology: from the clinic to cellular biology and back again. Proc Nutr Soc 58: 681-3.
28. Barber MD, Ross JA, Fearon KC (1999) Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35: 106-110. (Pubitemid 30115119)
29. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, et al. (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39: 210-213. (Pubitemid 33694037)
30. Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22: 33-40.
31. Gourzones C, Barjon C, Busson P (2012) Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol 22: 127-36.
32. Busson P, Ganem G, Flores P, Mugneret F, Clausse B, et al. (1988) Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42: 599-606. (Pubitemid 18264074)
33. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, et al. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97: 339-345. (Pubitemid 32060315)
34. McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67: 257-62.
35. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, et al. (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47: 2633-41.
36. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case- control study in general practice research database. BMJ 320: 1642-6. (Pubitemid 30364636)
37. Daugherty SE, Pfeiffer RM, Sigurdson AJ, Hayes RB, Leitzmann M, et al. (2011) Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. Am J Epidemiol 173: 721-30.